Riskpilot← Back to searchSign inGet full accessNOMVEC AS
ASActiveOrg 818142382C/O Legemiddelindustrien 8.Etasje Essendrops Gate 3, 0368 OsloComputer consultancy and computer facilities management activities · NACE 6220Est. 20164 employees
Revenue 2024
NOK 23,4M
+36% vs 2023
EBITDA margin
3.1%
+123% vs 2023
Equity ratio
71.1%
Financial strength
Net profit 2024
NOK 935K
+126% vs 2023
| Revenue | NOK 23,4M | +36% |
| EBITDA | NOK 727K | +123% |
| Net profit | NOK 935K | +126% |
| Total assets | NOK 12M | +18% |
| Equity | NOK 8,5M | +12% |
| Employees | 4 | — |
Legal name
NOMVEC AS
Org number
818142382
Legal form
Aksjeselskap
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
5. desember 2016
Share capital
NOK 1 000 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Eie, drive og administrere en norsk database (verifikasjonssystem) som skal være knyttet opp mot en sentral europeisk database eiet av foreningen "european medicines verification organisation - emvo". Selskapet har ikke erverv til formål.
Address
C/O Legemiddelindustrien 8.Etasje Essendrops Gate 3, 0368 Oslo
Phone
+4723161500
Email
post@nomvec.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 9 984 | 22 438 | 20 826 | 16 544 | 21 596 | 16 965 | 17 228 | 23 432 |
| Staff expenses | −0 | −869 | −2 305 | −2 472 | −3 681 | −4 289 | −4 859 | −5 673 | −6 301 |
| EBITDA | −9 | 2 556 | 10 751 | 3 966 | −2 542 | 4 647 | −2 066 | −3 184 | 727 |
| Depreciation & amort. | −0 | −857 | −1 181 | −1 509 | −1 506 | −1 494 | −666 | −449 | −115 |
| EBIT | −9 | 1 699 | 9 570 | 2 457 | −4 048 | 3 153 | −2 732 | −3 634 | 613 |
| Net financials | 0 | −100 | −1 | 100 | 51 | 0 | 14 | 86 | 323 |
| Profit before tax | −9 | 1 599 | 9 569 | 2 558 | −3 997 | 3 154 | −2 719 | −3 548 | 935 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −9 | 1 599 | 9 569 | 2 558 | −3 997 | 3 154 | −2 719 | −3 548 | 935 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 793 | 8 984 | 14 372 | 16 165 | 13 100 | 16 960 | 13 493 | 10 161 | 12 013 |
| Equity | 991 | 2 590 | 12 159 | 14 717 | 10 720 | 13 873 | 11 155 | 7 607 | 8 542 |
| Long-term debt | 2 500 | 4 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 302 | 1 894 | 2 212 | 1 448 | 2 380 | 3 087 | 2 338 | 2 555 | 3 471 |
| Total debt | 2 802 | 6 394 | 2 212 | 1 448 | 2 380 | 3 087 | 2 338 | 2 555 | 3 471 |
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
20162024
Equity ratio
71.1%
This company
38.2%
Market median
+86% vs market
20162024
Return on equity
10.9%
This company
18.4%
Market median
+41% vs market
20162024
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20162024
Asset turnover
1.95×
This company
1.12×
Market median
+74% vs market
20162024
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20162024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SL Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NOMVEC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sissel Lønning Andresen | Chief Executive Officer | 0 companies |
| Kai Mjaanes | Chief Executive Officer | 0 companies |
| Asbjørn Randen | Board of Directors | 0 companies |
| Lena Nymo Helli | Chairman | 0 companies |
| Anne Sofie Risåsen | Board of Directors | 0 companies |
| Leif Rune Skymoen | Chairman | 0 companies |
| Erling Ulltveit | Board of Directors | 0 companies |
| Ole Henrik Eriksen | Board of Directors | 0 companies |